House Bill No. by Representative Jordan aims to regulate the pricing of GLP-1 medications for health insurance plans in Louisiana. The bill enacts new provisions under R.S. 22:1034.2, which stipulate that health coverage plans cannot impose a cost-sharing requirement exceeding $200 for a 30-day supply of GLP-1 medications, regardless of the type or amount of medication prescribed. Additionally, the bill defines key terms related to drug formularies, enrollees, and GLP-1 medications, ensuring clarity in its application.

Furthermore, the bill introduces R.S. 40:1259.11, which mandates that the Louisiana Medicaid program provide coverage for GLP-1 medications to eligible individuals without regard to their specific medical conditions or diagnoses. This provision aims to enhance access to these medications for Medicaid recipients. The Louisiana Department of Health is also authorized to seek necessary federal approvals to implement these changes effectively. Overall, the bill seeks to improve affordability and accessibility of GLP-1 medications across various health coverage plans in the state.